skip to main content
Idioma:
Resultados 1 2 3 4 next page
Refinado por: Base de dados/Biblioteca: Elsevier ClinicalKey Journals remover assunto: Hematology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia

Short, Nicholas J. ; Montalban-Bravo, Guillermo ; Hwang, Hyunsoo ; Ning, Jing ; Franquiz, Miguel J. ; Kanagal-Shamanna, Rashmi ; Patel, Keyur P. ; DiNardo, Courtney D. ; Ravandi, Farhad ; Garcia-Manero, Guillermo ; Takahashi, Koichi ; Konopleva, Marina ; Daver, Naval ; Issa, Ghayas C. ; Andreeff, Michael ; Kantarjian, Hagop ; Kadia, Tapan M.

Blood advances, 2020-11, Vol.4 (22), p.5681-5689 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Acute myeloid leukaemia
Acute myeloid leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acute myeloid leukaemia

Short, Nicholas J ; Rytting, Michael E ; Cortes, Jorge E

The Lancet (British edition), 2018-08, Vol.392 (10147), p.593-606 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?
Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?

Short, Nicholas J ; Kantarjian, Hagop ; Jabbour, Elias ; Ravandi, Farhad

Best practice & research. Clinical haematology, 2017-09, Vol.30 (3), p.193-200 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
SOHO State of the Art Updates & Next Questions: Intensive and Non–Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
SOHO State of the Art Updates & Next Questions: Intensive and Non–Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

SOHO State of the Art Updates & Next Questions: Intensive and Non–Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Short, Nicholas J. ; Kantarjian, Hagop ; Jabbour, Elias

Clinical lymphoma, myeloma and leukemia, 2022-02, Vol.22 (2), p.61-66 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past
Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past
Material Type:
Artigo 		Adicionar ao Meu Espaço

Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past

Short, Nicholas J ; Kantarjian, Hagop

The Lancet. Haematology, 2023-05, Vol.10 (5), p.e382-e388 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia

Short, Nicholas J ; Kantarjian, Hagop

The Lancet. Haematology, 2022-07, Vol.9 (7), p.e535-e545 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia

Assi, Rita ; Kantarjian, Hagop ; Short, Nicholas J. ; Daver, Naval ; Takahashi, Koichi ; Garcia-Manero, Guillermo ; DiNardo, Courtney ; Burger, Jan ; Cortes, Jorge ; Jain, Nitin ; Wierda, William ; Chamoun, Salim ; Konopleva, Marina ; Jabbour, Elias

Clinical lymphoma, myeloma and leukemia, 2017-12, Vol.17 (12), p.897-901 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study

Jabbour, Elias ; Short, Nicholas J ; Ravandi, Farhad ; Huang, Xuelin ; Daver, Naval ; DiNardo, Courtney D ; Konopleva, Marina ; Pemmaraju, Naveen ; Wierda, William ; Garcia-Manero, Guillermo ; Sasaki, Koji ; Cortes, Jorge ; Garris, Rebecca ; Khoury, Joseph D ; Jorgensen, Jeffrey ; Jain, Nitin ; Alvarez, Joie ; O'Brien, Susan ; Kantarjian, Hagop

The Lancet. Haematology, 2018-12, Vol.5 (12), p.e618-e627 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial

DiNardo, Courtney D ; Maiti, Abhishek ; Rausch, Caitlin R ; Pemmaraju, Naveen ; Naqvi, Kiran ; Daver, Naval G ; Kadia, Tapan M ; Borthakur, Gautam ; Ohanian, Maro ; Alvarado, Yesid ; Issa, Ghayas C ; Montalban-Bravo, Guillermo ; Short, Nicholas J ; Yilmaz, Musa ; Bose, Prithviraj ; Jabbour, Elias J ; Takahashi, Koichi ; Burger, Jan A ; Garcia-Manero, Guillermo ; Jain, Nitin ; Kornblau, Steven M ; Thompson, Philip A ; Estrov, Zeev ; Masarova, Lucia ; Sasaki, Koji ; Verstovsek, Srdan ; Ferrajoli, Alessandra ; Weirda, William G ; Wang, Sa A ; Konoplev, Sergej ; Chen, Zhining ; Pierce, Sherry A ; Ning, Jing ; Qiao, Wei ; Ravandi, Farhad ; Andreeff, Michael ; Welch, John S ; Kantarjian, Hagop M ; Konopleva, Marina Y

The Lancet. Haematology, 2020-10, Vol.7 (10), p.e724-e736 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Acute Myeloid Leukemia: Past, Present, and Prospects for the Future
Acute Myeloid Leukemia: Past, Present, and Prospects for the Future
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acute Myeloid Leukemia: Past, Present, and Prospects for the Future

Short, Nicholas J ; Ravandi, Farhad

Clinical lymphoma, myeloma and leukemia, 2016-08, Vol.16, p.S25-S29 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2017  (2)
  2. 2017Até2018  (5)
  3. 2019Até2020  (9)
  4. 2021Até2023  (19)
  5. Após 2023  (6)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.